Join our Mailing List
Stay informed about medical and quality-of-life issues by becoming a part of the LBBC family.
Welcome to lbbc.org's website community for women living with metastatic breast cancer. We are dedicated to assisting you, and these pages offer easy access to a wealth of cutting-edge information specific to your needs.
In this community, you can read about the latest news on advanced disease, treatments and updates on clinical trials. Use the navigation bar on the left to quickly and easily access the topics of interest to you.
We hope the information and support offered in this section brings you comfort and enables you to make informed decisions regarding your physical and emotional health.
Donate Now
Every dollar you give helps LBBC continue to provide information and support at little to no cost.
- Small Increase of Metastatic Breast Cancer at First Diagnosis Seen in Young Women
- Doctors Should Discuss End-of-Life Care Earlier, Study Says
- FDA Approves T-DM1 for Treating HER2 Positive Metastatic Breast Cancer
- Advanced breast cancer inching up in young women
- FDA OKs Roche drug for late-stage metastatic breast cancer
Trial Examines Value of Circulating Cancer Cells in Metastatic Cancer
SWOG-S0500 is a clinical trial studying whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not.
October 2012 Ask the Expert: Metastatic Breast Cancer Symptoms and Side Effects
Living Beyond Breast Cancer expert Virginia F. Borges, MD, MMSc, answers your questions about managing symptoms and side effects caused by ongoing treatment for metastatic disease.


LBBC on Facebook
Learn about palliative care and how it helps manage physical and mental symptoms. Sherri West shares her story about maintaining balance and taking control after a metastatic breast cancer diagnosis.
Health Monitor's Guide to Metastatic Cancer helps you learn how to make important decisions, understand your treatment options and get the support you need.
